Molecular Pharmaceutics

Molecular Pharmaceutics is a peer-reviewed scientific journal, published since 2004 by the American Chemical Society. MP is currently indexed in: Chemical Abstracts Service (CAS), SCOPUS, EBSCOhost, British Library, PubMed, CABI, Web of Science, Proquest and SwetsWise. The current Editor is Gordon L. Amidon. Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development. Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Theoretical and experimental peer-reviewed communications, full-length research papers, brief articles, and critical reviews are welcomed. Molecular Pharmaceutics publishes Reviews, Articles, Brief Articles and Communications. MP has an Impact Factor of 5.400 as reported by the 2010 Journal Citation Reports by Thomson Reuters. The proper

Publisher
American Chemical Society
Country
United States
History
2004-present
Website
http://pubs.acs.org/journal/mpohbp
Impact factor
5.400 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Oncology & Cancer

New strategy for treating the most aggressive type of brain cancer

Researchers from the University of São Paulo (USP) in Brazil have developed a strategy for treating the most aggressive type of brain cancer in adults that combines a photoactive molecule and a chemotherapeutic agent—both ...

Neuroscience

Cannabidiol could help deliver medications to the brain

Cannabidiol (CBD), a non-psychoactive compound in cannabis, is being touted as beneficial for many health conditions, ranging from anxiety to epilepsy. Although much more research is needed to verify these claims, scientists ...

Oncology & Cancer

Pill for breast cancer diagnosis may outperform mammograms

As many as one in three women treated for breast cancer undergo unnecessary procedures, but a new method for diagnosing it could do a better job distinguishing between benign and aggressive tumors.

Medications

Heroin vaccine blocks lethal overdose

Scientists at The Scripps Research Institute (TSRI) have achieved a major milestone toward designing a safe and effective vaccine to both treat heroin addiction and block lethal overdose of the drug. Their research, published ...

Alzheimer's disease & dementia

Investigation into new molecules for potential Alzheimer's treatment

Two significant research studies have been published in Molecular Pharmaceutics and Current Alzheimer Research regarding molecules that could potentially treat Alzheimer's disease. The chief researcher in both studies was ...

Medical research

Intestinal flora effects drug response

Intestinal flora has multiple influences on human health, but researchers have revealed that it is also likely to have an effect on the body's response to drugs. Recent research from Kumamoto University in Japan strongly ...

Oncology & Cancer

Research suggests new tool for cancer treatment based on cell type

A new tumor model has been shown to predict how certain types of cancer cells react differently to a commonly used chemotherapy drug, a potential tool for "precision medicine," in which drug treatment is tailored to individual ...

page 1 from 3